Table 2 Relationship between TMED3 expression and tumor characteristics in patients with osteosarcoma
From: TMED3/RPS15A Axis promotes the development and progression of osteosarcoma
Features | No. of patients | TMED3 expression | P value | |
|---|---|---|---|---|
Low | High | |||
All patients | 55 | 34 | 21 | Â |
Age (years) | ||||
 < 28 | 26 | 15 | 11 |  0.555 |
 ≥ 28 | 29 | 19 | 10 | |
Gender | ||||
 Male | 37 | 23 | 14 |  0.941 |
 Female | 18 | 11 | 7 | |
Tumor size | ||||
 < 6 | 11 | 8 | 3 | 0.395 |
 ≥ 6 | 26 | 15 | 11 | |
T infiltrate | ||||
 T1 | 27 | 21 | 6 |  0.007 |
 T2 | 25 | 13 | 12 |  |
 T3 | 3 | 0 | 3 |  |
lymphatic metastasis (N) | ||||
 N0 | 52 | 34 | 18 |  0.025 |
 N1 | 3 | 0 | 3 | |
Stage | ||||
 1 | 1 | 1 | 0 |  0.021 |
 2 | 51 | 33 | 18 | |
 4 | 3 | 0 | 3 | |
RPS15A | ||||
 0 | 27 | 15 | 12 |  0.182 |
 1 | 23 | 17 | 6 | |